An RNA editing fingerprint of cancer stem cell reprogramming.
Crews, Leslie A; Jiang, Qingfei; Zipeto, Maria A; Lazzari, Elisa; Court, Angela C; Ali, Shawn; Barrett, Christian L; Frazer, Kelly A; Jamieson, Catriona H M.
J Transl Med
; 13: 52, 2015 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-25889244
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options.
Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.
What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
Attacking cancer at its root.
The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.